Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders

摘要: tion of pulse pressure does not necessarily parallel that systolic and diastolic blood pressure. J Hypertens 2000;18:1159–1163. 2. Sesso HD, Stampfer MJ, Rosner B, Gaziano JM, Hennekens CH. Two-year changes in subsequent risk cardiovascular disease men. Circulation 2000;102:307–312. 3. Benetos A, Zureik M, Morcet J, Thomas F, Bean K, Safar Ducimetiere P, Guize L. A decrease combined with an increase is associated a higher mortality Am Coll Cardiol 2000;35:673–680. 4. Verdecchia Porcellati C, Schillaci G, Borgioni Ciucci Battistelli Guerrieri Gatteschi Zampi I, Santucci Reboldi G. Ambulatory pressure: independent predictor prognosis essential hypertension (erratum). Hypertension 1995;25:462. 5. P. High-normal serum creatinine hypertension. Arch Intern Med 2001;161:886–891. 6. Mancia Zanchetti Agabiti-Rosei E, Benemio De Cesaris R, Fogari Pessina Rappelli Salvetti et al. superior to clinic predicting treatment-induced regression left ventricular hypertrophy. 1997;95:1464–1470. 7. Pede S, C. potent total 1998;32:983–988. 8. Parati monitoring organ damage. 2000;36:894–900. 9. Bertinieri Grassi Pomidossi Ferrari Gregorini L, A. Effects measured by the doctor on patient’s heart rate. Lancet 1983;2:695–698. 10. Khattar RS, Senior Lahiri Cardiovascular outcome white-coat versus sustained mild hypertension: 10 year follow-up study. 1998;98: 1982–1987. 11. Staessen JA, Thijs Fagard O’Brien ET, Clement D, de Leeuw PW, Nachev Palatini Tuomilehto Webster J. Predicting using conventional vs ambulatory older patients JAMA 1999;282:539–546. 12. Redon Campos Narciso ML, Rodicio JL, Pascual Ruilope LM. Prognostic value refractory prospective 1998;31:712–718. 13. Ohkubo T, Imai Y, Tsuji Nagai Watanabe N, Minami Itoh O, Bando Sakuma Fukao Satoh H, Hisamichi Abe K. Prediction screening measurements: pilot study Ohasama. 1997;15:357–364.